Patsalos P, Duncan J
Drug Saf. 1993; 9(3):156-84.
PMID: 8240723
DOI: 10.2165/00002018-199309030-00003.
Bartels H
Eur J Pediatr. 1980; 133(3):193-9.
PMID: 6993208
DOI: 10.1007/BF00496076.
Rylance G, Moreland T
Arch Dis Child. 1980; 55(2):89-98.
PMID: 6990880
PMC: 1626686.
DOI: 10.1136/adc.55.2.89.
von OLDERSHAUSEN H, Held H, Remmer H
Klin Wochenschr. 1970; 48(9):565-7.
PMID: 5474673
DOI: 10.1007/BF01488573.
Kahl G
Klin Wochenschr. 1971; 49(7):384-96.
PMID: 5102481
DOI: 10.1007/BF01484994.
Pharmacokinetics of single and multiple doses of phenytoin in man.
Lund L, Alvan G, Berlin A, Alexanderson B
Eur J Clin Pharmacol. 1974; 7(2):81-6.
PMID: 4853604
DOI: 10.1007/BF00561319.
Effect of diphenylhydantoin on hepatic drug hydroxylation.
Petruch F, Schuppel R, Steinhilber G
Eur J Clin Pharmacol. 1974; 7(4):281-5.
PMID: 4851632
DOI: 10.1007/BF00560345.
Effect of dosage increments on blood phenytoin concentrations.
Bochner F, Hooper W, Tyrer J, Eadie M
J Neurol Neurosurg Psychiatry. 1972; 35(6):873-6.
PMID: 4647859
PMC: 494195.
DOI: 10.1136/jnnp.35.6.873.
Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects.
KUTT H, Louis S
Drugs. 1972; 4(3):227-55.
PMID: 4405017
DOI: 10.2165/00003495-197204030-00003.
Determination of drug metabolizing enzymes in needle biopsies of human liver.
Schoene B, Fleischmann R, Remmer H, von OLDERSHAUSEN H
Eur J Clin Pharmacol. 1972; 4(2):65-73.
PMID: 4144102
DOI: 10.1007/BF00562499.
[Control of long-term therapy with diphenylhydantoin. Gas-chromatographic determination of diphenylhydantoin and hydroxy-diphenylhydantoin].
Mascher J, Bernhardt W
Z Neurol. 1973; 204(3):179-92.
PMID: 4123516
Laudatio to Herbert Remmer.
Greim H
Arch Toxicol. 1987; 60(1-3):1-4.
PMID: 3304201
DOI: 10.1007/BF00296938.
Diphenylhydantoin: correlation between protein binding and albumin concentration.
Gugler R, AZARNOFF D, Shoeman D
Klin Wochenschr. 1975; 53(9):445-6.
PMID: 1152355
DOI: 10.1007/BF01493371.
Clinical pharmacokinetics in infants and children.
Rane A, Wilson J
Clin Pharmacokinet. 1976; 1(1):2-24.
PMID: 1017153
DOI: 10.2165/00003088-197601010-00002.
[Plasma concentrations after injection or infusion of phenytoin (author's transl)].
Schmidt D, Vogel A
Klin Wochenschr. 1977; 55(5):219-23.
PMID: 846182
DOI: 10.1007/BF01487714.
Drug interactions and clinical pharmacokinetics.
Kristensen M
Clin Pharmacokinet. 1976; 1(5):351-72.
PMID: 797504
DOI: 10.2165/00003088-197601050-00003.
Control of epilepsy with a single daily dose of phenytoin sodium.
Cocks D, Critchley E
Br J Clin Pharmacol. 1975; 2(5):449-53.
PMID: 786358
PMC: 1402625.
DOI: 10.1111/j.1365-2125.1975.tb00555.x.
[Selected clinical aspects of routine monitoring of anticonvulsant concentrations in serum (author's transl)].
Heipertz R, Pilz H, Eickhoff K, Seidel D
Arch Psychiatr Nervenkr (1970). 1977; 224(4):361-78.
PMID: 606207
DOI: 10.1007/BF00341618.
Kinetics of placentally transferred phenytoin and its p-hydroxylated metabolites in newborn infants.
Rane A, Hoppel C, Hojer B
Br J Clin Pharmacol. 1979; 8(5):465-8.
PMID: 508552
PMC: 1429825.
DOI: 10.1111/j.1365-2125.1979.tb01027.x.
